Skip to search.
 STI Up 0.36%

Biogen Inc. (BIIB)

-NasdaqGS
312.96 Up 3.14(1.01%) 23:33 SGT - Nasdaq Real Time Price
Prev Close:309.82
Open:309.78
Bid:311.94 x 200
Ask:312.14 x 100
1y Target Est:344.61
Beta:0.398444
Next Earnings Date:26-Oct-16BIIB Earnings announcement
Day's Range:307.50 - 313.19
52wk Range:223.02 - 333.65
Volume:351,848
Avg Vol (3m):1,801,010
Market Cap:68.58B
P/E (ttm):18.28
EPS (ttm):17.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 1.01%68.58B
PFEUp 0.30%204.66B
ABTUp 0.44%61.54B

Key Statistics

Forward P/E (1 yr):14.97
P/S (ttm):6.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.10
Quarterly EPS Est (Sep-16) :5.01
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.80

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback